Epidémiologie, stratégies thérapeutiques et virologie cliniques dans l'infection à VIH
Accueil
FHDH
A propos de la base
Déjà 20 ans !
DOMEVIH
Principaux résultats
- RICE février 2013
- Publications
L'équipe
- Le GEC
- U1136 (ex-U943)
Collaborations
Etudes cliniques
ONCOVIH
Autres études
EPIDERMAS
FranceCoag
Doctorants - post-docs
EPICLIN 2010

Liste des publications à partir des données
de la base FHDH

2012 2011 2010
2005-2009 2000-2004 1992-1999

2010       89  
Abgrall S, Del Giudice P, Melica G, Costagliola D, on behalf of FHDH-ANRS CO4.
-->  HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years.
---->  AIDS 2010; 24(5):763-771.
        90  
Cain LE, Robins JM, Lanoy E, Logan R, Costagliola D, Hernán MA.
-->  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.
---->  Int J Biostat 2010; 6(2): 18.
        91  
Colin X, Lafuma A, Costagliola D, Lang JM, Guillon P.
-->  The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France.
---->  Pharmacoeconomics. 2010 Dec 23;28 (S1):59-68.
      92  
Colin X, Lafuma A, Costagliola D, Smets E, Mauskopf J, Guillon P.
-->  Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.
---->  Pharmacoeconomics. 2010 Dec 23;28 (S1):183-197.
      93  
Fontas E, Kousignian I, Pradier C, Poizot-Martin I, Durier C, Weiss L, Levy Y, Costagliola D, on behalf of FHDH ANRS CO4 and ANRS CO14.
-->  IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy. Results from the ANRS CO4 cohort.
---->  J Antimicrob Chemoth 2010; 65(10): 2215-2223.
      94  
Gill J, May M, Lewden C, Saag M, Mugavero M, Reiss P, Ledergerber B, Mocroft A, Harris R, Fux CA, Justice A, Costagliola D, Casabona J, Hogg RS, Khaykin P, Lampe F, Vehreschild J, Sterne JAC.
-->  Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies.
---->  Clin Infect Dis 2010; 50(10): 1387-1396.
      95  
Kousignian I, Launay O, Mayaud C, Rabaud C, Costagliola D, Abgrall S; on behalf of the FHDH-ANRS CO4.
-->  Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?
---->  J Antimicrob Chemoth 2010; 65(1):138-144.
      96  
Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Bingham A, Costagliola D for the Clinical Epidemiology Group of the French Hospital Database on HIV.
-->  Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population.
---->  AIDS 2010; 24(8): 1228-1230.
      97  
Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Costagliola D for the Clinical Epidemiology Group of the French Hospital Database on HIV.
-->  Impact of individual antiretroviral drugs on the risk of myocardial infarction in HIV-infected patients: a case-control study nested within the FHDH ANRS Cohort CO4.
---->  Arch Intern Med 2010; 170(14): 1228-1238.
      98  
Lodi S, Guiguet M, Costagliola D, Fisher M, De Luca A, Porter K and the CASCADE collaboration.
-->  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
---->  JNCI 2010; 102(11):784-92.
      99  
Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, Chêne G, Vanhems P, Porter K, on behalf of the Cascade Collaboration.
-->  CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era.
---->  AIDS. 2010; 24(17):2697-704.
      100  
Lodwick L, Costagliola D, Reiss P, Carlo Torti C, Teira R, Dorrucci M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, García F, De Wit S, Castagna A, Antinori A, Judd A, Ghosn J, Touloumi G, Mussini C, Duval X, Ramos J, Meyer L, Warsawski J, Thorne C, Masip J, Perez-Hoyos S, Tookey P, Pillay D, van Sighem A, Lo Caputo S, Günthard H, Paredes R, De Luca A, Paraskevis D, Fabre-Colin C, Kjaer J, Chêne G, Lundgren J, Phillips A.
-->  Triple class virologic failure in HIV-infected patients on antiretroviral therapy for up to 10 years.
---->  Arch Intern Med 2010; 170(5):410-419.
        101   
Ray M, Logan R, Sterne JAC, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA.
-->  The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
---->  AIDS 2010; 24: 123-137.
      102  
Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC; CASCADE Collaboration Members.
-->  Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy—the CASCADE collaboration: a collaboration of 23 cohort studies.
---->  PLoS Med. 2010; 7(2): e1000239.
      103  
Yazdanpanah Y, Sloan C.E, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, Pillonel J, Poullié AI, Scemama O, Deuffic-Burban S, Losina E, Walensky RP, Freedberg KA, Paltiel AD.
-->  Routine HIV screening in France: clinical impact and cost-effectiveness.
---->  PLoS One 2010; 5(10): e13132.
Adresse Mentions légales Extranet Administration